

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.08391989 |
| 2 | inositol phosphate catabolic process (GO:0071545) | 4.84567442 |
| 3 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.82954347 |
| 4 | inositol phosphate dephosphorylation (GO:0046855) | 4.82954347 |
| 5 | protein-cofactor linkage (GO:0018065) | 4.55146719 |
| 6 | sleep (GO:0030431) | 4.49768286 |
| 7 | ubiquinone biosynthetic process (GO:0006744) | 4.42400468 |
| 8 | magnesium ion transport (GO:0015693) | 4.34940127 |
| 9 | mitotic cell cycle arrest (GO:0071850) | 4.23092145 |
| 10 | ubiquinone metabolic process (GO:0006743) | 4.12571664 |
| 11 | endoderm formation (GO:0001706) | 4.05690206 |
| 12 | organelle disassembly (GO:1903008) | 4.02508801 |
| 13 | positive regulation of glycolytic process (GO:0045821) | 3.98129290 |
| 14 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.87959377 |
| 15 | DNA methylation involved in gamete generation (GO:0043046) | 3.83255772 |
| 16 | behavioral response to ethanol (GO:0048149) | 3.77420664 |
| 17 | rRNA modification (GO:0000154) | 3.76143804 |
| 18 | polyol catabolic process (GO:0046174) | 3.75150781 |
| 19 | maturation of 5.8S rRNA (GO:0000460) | 3.68840051 |
| 20 | quinone biosynthetic process (GO:1901663) | 3.68374520 |
| 21 | piRNA metabolic process (GO:0034587) | 3.55579485 |
| 22 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.51686945 |
| 23 | negative regulation of T cell apoptotic process (GO:0070233) | 3.44037200 |
| 24 | parturition (GO:0007567) | 3.36192556 |
| 25 | N-glycan processing (GO:0006491) | 3.33975283 |
| 26 | response to pheromone (GO:0019236) | 3.31714583 |
| 27 | response to muramyl dipeptide (GO:0032495) | 3.31372332 |
| 28 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.31226292 |
| 29 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.25555672 |
| 30 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.22972611 |
| 31 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.20724137 |
| 32 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.20724137 |
| 33 | aspartate family amino acid catabolic process (GO:0009068) | 3.20214891 |
| 34 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.17650987 |
| 35 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.15426932 |
| 36 | L-fucose catabolic process (GO:0042355) | 3.15353380 |
| 37 | fucose catabolic process (GO:0019317) | 3.15353380 |
| 38 | L-fucose metabolic process (GO:0042354) | 3.15353380 |
| 39 | tryptophan metabolic process (GO:0006568) | 3.15104414 |
| 40 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.07958614 |
| 41 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.06638840 |
| 42 | GPI anchor metabolic process (GO:0006505) | 3.03686029 |
| 43 | mannosylation (GO:0097502) | 3.00121587 |
| 44 | negative regulation of meiotic cell cycle (GO:0051447) | 2.99434235 |
| 45 | negative regulation of telomere maintenance (GO:0032205) | 2.98735662 |
| 46 | negative regulation of membrane potential (GO:0045837) | 2.97720440 |
| 47 | kynurenine metabolic process (GO:0070189) | 2.97179821 |
| 48 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.88085186 |
| 49 | protein polyglutamylation (GO:0018095) | 2.87863779 |
| 50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86289946 |
| 51 | positive regulation of mast cell degranulation (GO:0043306) | 2.86289946 |
| 52 | GPI anchor biosynthetic process (GO:0006506) | 2.85955942 |
| 53 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.85708773 |
| 54 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.83226446 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.83226446 |
| 56 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.80220088 |
| 57 | negative regulation of mast cell activation (GO:0033004) | 2.77861291 |
| 58 | regulation of relaxation of muscle (GO:1901077) | 2.77207330 |
| 59 | positive regulation of prostaglandin secretion (GO:0032308) | 2.75769845 |
| 60 | tRNA modification (GO:0006400) | 2.75076613 |
| 61 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.72766779 |
| 62 | ribonucleoprotein complex disassembly (GO:0032988) | 2.71676259 |
| 63 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.71432289 |
| 64 | negative regulation of astrocyte differentiation (GO:0048712) | 2.70918964 |
| 65 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.70093170 |
| 66 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.70093170 |
| 67 | cAMP catabolic process (GO:0006198) | 2.68813928 |
| 68 | adenosine metabolic process (GO:0046085) | 2.63690860 |
| 69 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.63681983 |
| 70 | sulfation (GO:0051923) | 2.60522046 |
| 71 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.60257847 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 2.59398719 |
| 73 | cullin deneddylation (GO:0010388) | 2.59009657 |
| 74 | opioid receptor signaling pathway (GO:0038003) | 2.58311255 |
| 75 | protein neddylation (GO:0045116) | 2.58253365 |
| 76 | peptidyl-arginine methylation (GO:0018216) | 2.58018235 |
| 77 | peptidyl-arginine N-methylation (GO:0035246) | 2.58018235 |
| 78 | primary amino compound metabolic process (GO:1901160) | 2.57684579 |
| 79 | regulation of thymocyte apoptotic process (GO:0070243) | 2.56635555 |
| 80 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56077552 |
| 81 | protein deneddylation (GO:0000338) | 2.55238955 |
| 82 | cytidine metabolic process (GO:0046087) | 2.55032770 |
| 83 | cytidine catabolic process (GO:0006216) | 2.55032770 |
| 84 | cytidine deamination (GO:0009972) | 2.55032770 |
| 85 | urinary tract smooth muscle contraction (GO:0014848) | 2.54093047 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.53634537 |
| 87 | nucleotide transmembrane transport (GO:1901679) | 2.53495545 |
| 88 | indole-containing compound metabolic process (GO:0042430) | 2.53209971 |
| 89 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.53148246 |
| 90 | behavioral response to nicotine (GO:0035095) | 2.51993210 |
| 91 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.50998159 |
| 92 | positive regulation of mast cell activation (GO:0033005) | 2.50863194 |
| 93 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.44982596 |
| 94 | quinone metabolic process (GO:1901661) | 2.44617108 |
| 95 | base-excision repair, AP site formation (GO:0006285) | 2.43969647 |
| 96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43800311 |
| 97 | neuronal action potential (GO:0019228) | 2.41878147 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.41801714 |
| 99 | negative regulation of cell killing (GO:0031342) | 2.41801714 |
| 100 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.41107946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IGF1R_20145208_ChIP-Seq_DFB_Human | 6.03090472 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.61375805 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.13777359 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86355832 |
| 5 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.78928010 |
| 6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.76083455 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.65961484 |
| 8 | FUS_26573619_Chip-Seq_HEK293_Human | 2.62550509 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.60301770 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.39678841 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.38532596 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.34511899 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31778954 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.26031597 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.15495723 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.06002110 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05182503 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.03343764 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.97115706 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83495422 |
| 21 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.68626281 |
| 22 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.68493282 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67756062 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.67363102 |
| 25 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.66269609 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62528566 |
| 27 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.59931616 |
| 28 | GATA3_26560356_Chip-Seq_TH2_Human | 1.58983674 |
| 29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.55299611 |
| 30 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.53646014 |
| 31 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.53646014 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53252900 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.51992342 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.51720815 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51584332 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47043876 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46025238 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.45832848 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43540663 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41903563 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38995563 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38560707 |
| 43 | AR_20517297_ChIP-Seq_VCAP_Human | 1.36777808 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35233168 |
| 45 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.32001718 |
| 46 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30183776 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30145933 |
| 48 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29765262 |
| 49 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29765262 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28922615 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26369923 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23953325 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23717225 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23481919 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22390233 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21536299 |
| 57 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.17686091 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17040716 |
| 59 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17040716 |
| 60 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16895720 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13977858 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13865171 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12057114 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11051959 |
| 65 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11048839 |
| 66 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10157287 |
| 67 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09698052 |
| 68 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09059363 |
| 69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07710059 |
| 70 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07212387 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06784613 |
| 72 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06187889 |
| 73 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.05515561 |
| 74 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05156946 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02743558 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02622358 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01102815 |
| 78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00923488 |
| 79 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.00230017 |
| 80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99943428 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99943428 |
| 82 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99294391 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 0.98235325 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.96867400 |
| 85 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96553751 |
| 86 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.96480051 |
| 87 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95397557 |
| 88 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.95153478 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94725675 |
| 90 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94138778 |
| 91 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94030352 |
| 92 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93417733 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93384217 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93174414 |
| 95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92953357 |
| 96 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91812432 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89844259 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89083487 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88483905 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88383676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 6.46620954 |
| 2 | MP0003724_increased_susceptibility_to | 4.22410041 |
| 3 | MP0006054_spinal_hemorrhage | 2.94440265 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 2.81419921 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.42570100 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 2.40494265 |
| 7 | MP0009046_muscle_twitch | 2.33077681 |
| 8 | MP0008872_abnormal_physiological_respon | 2.28507612 |
| 9 | MP0003252_abnormal_bile_duct | 2.21317059 |
| 10 | MP0009764_decreased_sensitivity_to | 2.19472786 |
| 11 | MP0003195_calcinosis | 2.14825632 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.13724721 |
| 13 | MP0008877_abnormal_DNA_methylation | 1.98109951 |
| 14 | MP0005646_abnormal_pituitary_gland | 1.87734443 |
| 15 | MP0002163_abnormal_gland_morphology | 1.80828301 |
| 16 | MP0004043_abnormal_pH_regulation | 1.80509194 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 1.79560156 |
| 18 | MP0002272_abnormal_nervous_system | 1.77658615 |
| 19 | MP0004147_increased_porphyrin_level | 1.76967905 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.71694514 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.67639703 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.64986344 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.53676663 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 1.53429495 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.52984931 |
| 26 | MP0000427_abnormal_hair_cycle | 1.51550181 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.46746296 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.45141640 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.43792647 |
| 30 | MP0001800_abnormal_humoral_immune | 1.42621282 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.42355694 |
| 32 | MP0006292_abnormal_olfactory_placode | 1.37009683 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.32759109 |
| 34 | MP0009785_altered_susceptibility_to | 1.31257245 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.30321621 |
| 36 | MP0004924_abnormal_behavior | 1.30321621 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.28302345 |
| 38 | MP0000230_abnormal_systemic_arterial | 1.28146986 |
| 39 | MP0002723_abnormal_immune_serum | 1.27744266 |
| 40 | MP0004885_abnormal_endolymph | 1.27357586 |
| 41 | MP0003718_maternal_effect | 1.27147426 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.26534988 |
| 43 | MP0005671_abnormal_response_to | 1.25403319 |
| 44 | MP0009745_abnormal_behavioral_response | 1.23575124 |
| 45 | MP0002736_abnormal_nociception_after | 1.23249595 |
| 46 | MP0005253_abnormal_eye_physiology | 1.21471498 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.20541697 |
| 48 | MP0003828_pulmonary_edema | 1.20475346 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.20011600 |
| 50 | MP0002928_abnormal_bile_duct | 1.19960356 |
| 51 | MP0008775_abnormal_heart_ventricle | 1.17690037 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14890388 |
| 53 | MP0002254_reproductive_system_inflammat | 1.14386603 |
| 54 | MP0002282_abnormal_trachea_morphology | 1.13672620 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.12581893 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.11306663 |
| 57 | MP0000685_abnormal_immune_system | 1.10823061 |
| 58 | MP0003638_abnormal_response/metabolism_ | 1.08399890 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.08242151 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.06522516 |
| 61 | MP0006082_CNS_inflammation | 1.05324261 |
| 62 | MP0002419_abnormal_innate_immunity | 1.04056596 |
| 63 | MP0004142_abnormal_muscle_tone | 1.04020779 |
| 64 | MP0001835_abnormal_antigen_presentation | 1.04020510 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.03422278 |
| 66 | MP0003436_decreased_susceptibility_to | 1.03027467 |
| 67 | MP0001764_abnormal_homeostasis | 1.01474448 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.00482642 |
| 69 | MP0004484_altered_response_of | 1.00199657 |
| 70 | MP0001819_abnormal_immune_cell | 1.00054385 |
| 71 | MP0009763_increased_sensitivity_to | 0.99350498 |
| 72 | MP0005266_abnormal_metabolism | 0.94772698 |
| 73 | MP0001970_abnormal_pain_threshold | 0.93505445 |
| 74 | MP0003075_altered_response_to | 0.89231290 |
| 75 | MP0001533_abnormal_skeleton_physiology | 0.89055795 |
| 76 | MP0005165_increased_susceptibility_to | 0.88978469 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.87892565 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 0.87837442 |
| 79 | MP0001486_abnormal_startle_reflex | 0.86921268 |
| 80 | MP0001984_abnormal_olfaction | 0.85956819 |
| 81 | MP0002234_abnormal_pharynx_morphology | 0.85764136 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.84714031 |
| 83 | MP0006276_abnormal_autonomic_nervous | 0.84503937 |
| 84 | MP0005083_abnormal_biliary_tract | 0.84348792 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 0.82479191 |
| 86 | MP0001905_abnormal_dopamine_level | 0.82398854 |
| 87 | MP0005410_abnormal_fertilization | 0.82358534 |
| 88 | MP0002006_tumorigenesis | 0.79724907 |
| 89 | MP0002063_abnormal_learning/memory/cond | 0.78951799 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 0.77187072 |
| 91 | MP0001919_abnormal_reproductive_system | 0.76839263 |
| 92 | MP0003763_abnormal_thymus_physiology | 0.76651952 |
| 93 | MP0000716_abnormal_immune_system | 0.76418796 |
| 94 | MP0000689_abnormal_spleen_morphology | 0.74626977 |
| 95 | MP0003880_abnormal_central_pattern | 0.73466686 |
| 96 | MP0002102_abnormal_ear_morphology | 0.71708802 |
| 97 | MP0008469_abnormal_protein_level | 0.69974690 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.69936222 |
| 99 | MP0009278_abnormal_bone_marrow | 0.69583441 |
| 100 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68819829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dyschromatopsia (HP:0007641) | 5.51272922 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.31520347 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.31520347 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.31520347 |
| 5 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.21858306 |
| 6 | Focal motor seizures (HP:0011153) | 3.85329834 |
| 7 | Abolished electroretinogram (ERG) (HP:0000550) | 3.72763780 |
| 8 | Flat capital femoral epiphysis (HP:0003370) | 3.63130615 |
| 9 | Stomach cancer (HP:0012126) | 3.46381100 |
| 10 | Carpal bone hypoplasia (HP:0001498) | 3.29736366 |
| 11 | Attenuation of retinal blood vessels (HP:0007843) | 3.23245077 |
| 12 | Central scotoma (HP:0000603) | 3.21499453 |
| 13 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.99071640 |
| 14 | Visual hallucinations (HP:0002367) | 2.99047752 |
| 15 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.90961396 |
| 16 | Abnormality of alanine metabolism (HP:0010916) | 2.90961396 |
| 17 | Hyperalaninemia (HP:0003348) | 2.90961396 |
| 18 | Concave nail (HP:0001598) | 2.75729342 |
| 19 | Keratoconus (HP:0000563) | 2.72981290 |
| 20 | Increased corneal curvature (HP:0100692) | 2.72981290 |
| 21 | Colon cancer (HP:0003003) | 2.65303311 |
| 22 | Type II lissencephaly (HP:0007260) | 2.57326535 |
| 23 | Abnormality of T cell number (HP:0011839) | 2.51512407 |
| 24 | Methylmalonic acidemia (HP:0002912) | 2.50832909 |
| 25 | Large eyes (HP:0001090) | 2.49866608 |
| 26 | Abnormality of the renal cortex (HP:0011035) | 2.49382743 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.49281269 |
| 28 | Tongue fasciculations (HP:0001308) | 2.48685398 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46094411 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44468092 |
| 31 | Thyroid-stimulating hormone excess (HP:0002925) | 2.42019572 |
| 32 | Abnormality of the prostate (HP:0008775) | 2.41945225 |
| 33 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.38236652 |
| 34 | Absent/shortened dynein arms (HP:0200106) | 2.38236652 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.32082924 |
| 36 | Severe muscular hypotonia (HP:0006829) | 2.31532749 |
| 37 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30720676 |
| 38 | Molar tooth sign on MRI (HP:0002419) | 2.30257360 |
| 39 | Abnormality of midbrain morphology (HP:0002418) | 2.30257360 |
| 40 | Generalized myoclonic seizures (HP:0002123) | 2.23327405 |
| 41 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.22815071 |
| 42 | Muscle fibrillation (HP:0010546) | 2.18780388 |
| 43 | IgG deficiency (HP:0004315) | 2.16795422 |
| 44 | Hemiplegia (HP:0002301) | 2.15959941 |
| 45 | Pancreatic cysts (HP:0001737) | 2.13646977 |
| 46 | Autoimmune hemolytic anemia (HP:0001890) | 2.13236422 |
| 47 | Clumsiness (HP:0002312) | 2.11981129 |
| 48 | Abnormality of T cells (HP:0002843) | 2.10785071 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10369877 |
| 50 | Chorioretinal atrophy (HP:0000533) | 2.09371157 |
| 51 | Flared iliac wings (HP:0002869) | 2.08815194 |
| 52 | Acute encephalopathy (HP:0006846) | 2.08743705 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08728318 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08728318 |
| 55 | T lymphocytopenia (HP:0005403) | 2.08069943 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.07859909 |
| 57 | Opisthotonus (HP:0002179) | 2.02598971 |
| 58 | Methylmalonic aciduria (HP:0012120) | 2.01730423 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 2.01580693 |
| 60 | Hypoplasia of the uterus (HP:0000013) | 2.00396308 |
| 61 | Pachygyria (HP:0001302) | 1.98903664 |
| 62 | Congenital stationary night blindness (HP:0007642) | 1.98397922 |
| 63 | Long nose (HP:0003189) | 1.95428213 |
| 64 | Chronic diarrhea (HP:0002028) | 1.95124431 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 1.95039745 |
| 66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94014661 |
| 67 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94014661 |
| 68 | Abnormal protein glycosylation (HP:0012346) | 1.94014661 |
| 69 | Abnormal glycosylation (HP:0012345) | 1.94014661 |
| 70 | Recurrent bronchitis (HP:0002837) | 1.93087142 |
| 71 | Nephronophthisis (HP:0000090) | 1.92525688 |
| 72 | Abnormality of the femoral head (HP:0003368) | 1.90863859 |
| 73 | Parakeratosis (HP:0001036) | 1.90170718 |
| 74 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.89489557 |
| 75 | Scotoma (HP:0000575) | 1.89479770 |
| 76 | Prostate neoplasm (HP:0100787) | 1.89061141 |
| 77 | Conical tooth (HP:0000698) | 1.87852942 |
| 78 | Increased serum lactate (HP:0002151) | 1.86296122 |
| 79 | Decreased circulating renin level (HP:0003351) | 1.84651659 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 1.84429485 |
| 81 | Broad alveolar ridges (HP:0000187) | 1.84136884 |
| 82 | Pendular nystagmus (HP:0012043) | 1.83719827 |
| 83 | Delayed CNS myelination (HP:0002188) | 1.80779148 |
| 84 | Abnormality of the costochondral junction (HP:0000919) | 1.80337989 |
| 85 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.79762350 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 1.79471079 |
| 87 | Congenital, generalized hypertrichosis (HP:0004540) | 1.77420587 |
| 88 | Deformed sella turcica (HP:0002681) | 1.76666541 |
| 89 | Agitation (HP:0000713) | 1.75660839 |
| 90 | Decreased central vision (HP:0007663) | 1.75095001 |
| 91 | Metabolic alkalosis (HP:0200114) | 1.74957785 |
| 92 | Abnormal drinking behavior (HP:0030082) | 1.74880448 |
| 93 | Polydipsia (HP:0001959) | 1.74880448 |
| 94 | Optic neuritis (HP:0100653) | 1.71643684 |
| 95 | Retrobulbar optic neuritis (HP:0100654) | 1.71643684 |
| 96 | Constricted visual fields (HP:0001133) | 1.71152634 |
| 97 | Encephalitis (HP:0002383) | 1.69054463 |
| 98 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.67515858 |
| 99 | Hypothermia (HP:0002045) | 1.67382622 |
| 100 | Absence seizures (HP:0002121) | 1.66973081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.40204222 |
| 2 | TLK1 | 3.16548443 |
| 3 | MAP3K14 | 2.89052682 |
| 4 | EIF2AK3 | 2.78263654 |
| 5 | FRK | 2.77326232 |
| 6 | MAP4K2 | 2.69038156 |
| 7 | TAOK3 | 2.65812468 |
| 8 | TIE1 | 2.61599031 |
| 9 | EIF2AK2 | 2.48965756 |
| 10 | MAP2K2 | 2.46891947 |
| 11 | CAMKK2 | 2.46072746 |
| 12 | TXK | 2.44844425 |
| 13 | NTRK3 | 2.32621383 |
| 14 | GRK7 | 2.30402369 |
| 15 | BMPR1B | 2.26078720 |
| 16 | BRSK2 | 2.24449511 |
| 17 | BCR | 2.18170067 |
| 18 | SCYL2 | 1.89665867 |
| 19 | MAPK13 | 1.73224237 |
| 20 | OXSR1 | 1.72898083 |
| 21 | TEC | 1.61745049 |
| 22 | GRK1 | 1.57173561 |
| 23 | ADRBK2 | 1.55818570 |
| 24 | MAP2K6 | 1.51556757 |
| 25 | ZAK | 1.48208705 |
| 26 | IRAK4 | 1.46754211 |
| 27 | GRK6 | 1.44862680 |
| 28 | IKBKE | 1.44186771 |
| 29 | CDK19 | 1.41377646 |
| 30 | TNIK | 1.29150734 |
| 31 | PHKG2 | 1.25270853 |
| 32 | PHKG1 | 1.25270853 |
| 33 | TBK1 | 1.22774894 |
| 34 | CAMKK1 | 1.22213556 |
| 35 | MAP3K6 | 1.20721786 |
| 36 | TAF1 | 1.20565794 |
| 37 | ADRBK1 | 1.16701922 |
| 38 | CSNK1G3 | 1.15793915 |
| 39 | NEK6 | 1.15511712 |
| 40 | CSNK1A1L | 1.14532098 |
| 41 | ITK | 1.13012021 |
| 42 | KIT | 1.09623375 |
| 43 | IKBKB | 1.09425365 |
| 44 | NUAK1 | 1.09232104 |
| 45 | CSNK1G2 | 1.00771620 |
| 46 | CSF1R | 0.94738668 |
| 47 | GRK5 | 0.92057994 |
| 48 | TGFBR1 | 0.89654003 |
| 49 | TESK2 | 0.84791448 |
| 50 | PTK2B | 0.83436618 |
| 51 | ACVR1B | 0.78378993 |
| 52 | CSNK1G1 | 0.78335525 |
| 53 | SYK | 0.78188475 |
| 54 | PDK2 | 0.77711443 |
| 55 | PINK1 | 0.75724895 |
| 56 | ERBB3 | 0.74953013 |
| 57 | FGR | 0.74405538 |
| 58 | FES | 0.73336776 |
| 59 | WNK4 | 0.73238133 |
| 60 | CASK | 0.72249701 |
| 61 | MARK1 | 0.68420283 |
| 62 | STK38L | 0.68080402 |
| 63 | MAP2K1 | 0.67469980 |
| 64 | CHUK | 0.63724280 |
| 65 | MAP4K1 | 0.63429597 |
| 66 | RPS6KA4 | 0.62089834 |
| 67 | MAPKAPK3 | 0.61041764 |
| 68 | LCK | 0.59810999 |
| 69 | PLK3 | 0.58988484 |
| 70 | MAP2K3 | 0.56560007 |
| 71 | JAK3 | 0.56492289 |
| 72 | STK11 | 0.56336233 |
| 73 | FLT3 | 0.56028420 |
| 74 | EIF2AK1 | 0.55300240 |
| 75 | DYRK2 | 0.53977054 |
| 76 | TNK2 | 0.48646615 |
| 77 | IRAK1 | 0.47731181 |
| 78 | BRSK1 | 0.44143635 |
| 79 | PRKCQ | 0.43230738 |
| 80 | EPHA3 | 0.43227251 |
| 81 | PLK2 | 0.42021218 |
| 82 | ZAP70 | 0.40660057 |
| 83 | PAK6 | 0.40550711 |
| 84 | BMX | 0.39637272 |
| 85 | LIMK1 | 0.39117874 |
| 86 | MATK | 0.36238703 |
| 87 | BTK | 0.35845910 |
| 88 | WNK3 | 0.35595965 |
| 89 | PRKACB | 0.34344490 |
| 90 | LYN | 0.34248003 |
| 91 | IGF1R | 0.33003553 |
| 92 | PRKCI | 0.30716038 |
| 93 | VRK1 | 0.30417092 |
| 94 | MAP2K4 | 0.29857951 |
| 95 | BCKDK | 0.29818308 |
| 96 | PRKCE | 0.29687635 |
| 97 | TGFBR2 | 0.29525625 |
| 98 | CSNK1D | 0.29205094 |
| 99 | EGFR | 0.25994414 |
| 100 | CDK8 | 0.25737350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18026226 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.81320469 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.74745364 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.46560806 |
| 5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.43632686 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.39391028 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.36308268 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.36052395 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.31251572 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.29763409 |
| 11 | Basal transcription factors_Homo sapiens_hsa03022 | 2.22984089 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20871622 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.01646241 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01074414 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00868896 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.89396835 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.79370248 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.77298391 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.77161342 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59183985 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.57829740 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55225097 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48417948 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47851901 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43125297 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41935172 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41481411 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41462429 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37097568 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33048279 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.32795345 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30751494 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.30046661 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29969372 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.25720810 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21455307 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.14761532 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13536769 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13107414 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09458152 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07847978 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05319760 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05150886 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04269943 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03803089 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.03482115 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98948035 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94123195 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91836654 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91321394 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 0.90497031 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.88244761 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87482520 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87438631 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 0.82451576 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78951068 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78154686 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78094596 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.74579443 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73983793 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73438168 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.70952991 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70586937 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70330968 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69571009 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66762497 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.66671113 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65994430 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65505626 |
| 70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63962081 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63658758 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61856818 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60617272 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60343355 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58084046 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56636253 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55441979 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53703353 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50215455 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.49928752 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47888607 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47039209 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46739692 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45901978 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45152596 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44465220 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.44403682 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43599762 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42473423 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.41383880 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.40816061 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39828864 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38656903 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38266924 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37839968 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37361251 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36136501 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34768096 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33831568 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32363348 |

